Brainstorm cell therapeutics announces second quarter 2025 financial results and provides corporate update

Conference call and webcast scheduled for 8:30 a.m. eastern time today, thursday, august 14, 2025 new york , aug. 14, 2025 /prnewswire/ -- brainstorm cell therapeutics inc. (otcqb: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the second quarter ended june 30, 2025, and provided a corporate update.
BCLI Ratings Summary
BCLI Quant Ranking